what are the long term effects of glp-1 Ozempic, Wegovy, and Your Gut: Every Patient Needs to Know About Side what are the long term

Sickle cell anemia can reduce male sperm production itself through ischemic end-organ damage of the pituitary gland and testicles

During the series there are many flashbacks of Joes past as a child, it is always easy to distinguish flashbacks from the present as they appear in a blue lighting

MONDAY, June 8, 2026 (HealthDay News) -- Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with reduced risks for thromboembolic events, emergency department use, and mortality among adults with obesity and autoimmune diseases (AIDs), according to a study published online June 6 in the Journal of the American Heart Association to coincide with the annual meeting of the American Diabetes Association, held from June 5 to 8 in New Orleans.Hao Dai, Ph.D., from the Indiana University School of Medicine in Indianapolis, and colleagues conducted a retrospective cohort study, which emulated a target trial using 2014 to 2024 electronic health record data to examine the association between GLP-1 RA use and major adverse cardiovascular and thromboembolic event risk among adults with obesity and AID

Participants provided written informed consent to the study prior to any study procedures